Full-Time

Quality Project Management Specialist

Confirmed live in the last 24 hours

Legend Biotech

Legend Biotech

1,001-5,000 employees

Develops and commercializes cell therapies

Biotechnology
Healthcare

Senior

Bridgewater Township, NJ, USA

Hybrid position requiring in-office presence.

Category
Project Management
Business & Strategy
Requirements
  • A minimum of a Bachelor’s Degree
  • A Minimum of 5 years relevant work experience is required. It is preferable that the candidate have 2 years + of experience working in Quality Assurance. Previous cell therapy experience is a plus
  • Knowledge of cGMP regulations and Health Authority guidance related to manufacturing of cell-based products as well as knowledge of Good Tissue Practices
  • Ability to lead projects
  • Ability to facilitate meetings
  • Participated in Health Authority Inspections is a plus
  • Drive Change
  • Strong interpersonal and written/oral communication skills
  • Ability to handle multiple priorities daily while being flexible and responsive to frequently shifting priorities
  • Ability to independently perform assigned tasks
  • Ability to work with in a team environment
  • Ability to identify/remediate gaps in Quality processes or systems
  • Proficient with using Microsoft Office applications
  • Language: English
Responsibilities
  • Provide quality and compliance input for identified continuous improvement efforts associated with the manufacturing site
  • Lead assigned Quality tasks associated with process improvements
  • Participate/facilitate in escalations associated with batch investigations
  • Provide site Quality metrics
  • Collaborates with all Quality groups and functional departments to resolve issues
  • Provide quality support in cross-functional projects with many stakeholders
  • Perform tasks in a manner consistent with the safety policies, quality systems, and cGMP requirements
  • Require minimal direction to complete tasks, knows how to get resources and information from established internal contacts; escalates to management when problems are identified, consult with supervisor or other subject matter experts for decisions outside established processes
  • Drive continuous improvement
Desired Qualifications
  • Participated in Health Authority Inspections is a plus

Legend Biotech develops and commercializes cell therapies aimed at treating serious diseases, particularly cancers like hematological malignancies and solid tumors. Their approach is technology agnostic, allowing them to explore various methods to find effective treatments. The company operates in the personalized medicine sector, focusing on discovering, developing, and bringing new therapies to market. They generate revenue through licensing and selling their therapies, including CAR-T therapies, which involve modifying a patient's own cells to combat cancer. Legend Biotech emphasizes transparency with investors, regularly updating them on financial results and business developments.

Company Stage

IPO

Total Funding

$146.4M

Headquarters

Franklin Township, New Jersey

Founded

2014

Growth & Insights
Headcount

6 month growth

0%

1 year growth

-1%

2 year growth

0%
Simplify Jobs

Simplify's Take

What believers are saying

  • Recent FDA and European approvals for CARVYKTI® expand its market reach in multiple myeloma.
  • New R&D facility in Philadelphia boosts innovation in next-generation cell therapies.
  • Alan Bash's appointment could accelerate CARVYKTI®'s growth and market penetration.

What critics are saying

  • Increased competition from Amgen's Imdelltra may impact CAR-T therapy focus.
  • Collaboration with Multiply Labs may face technological challenges, delaying production timelines.
  • Financial strain from new R&D facility could affect operational focus if advancements lag.

What makes Legend Biotech unique

  • Legend Biotech focuses on novel cell therapies for oncology, including CAR-T and NK cells.
  • The company is technology agnostic, exploring multiple platforms for effective cancer treatments.
  • Legend Biotech's CARVYKTI® is the first BCMA-targeted CAR-T therapy approved for second-line use.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Paid Sick Leave

Paid Holidays

Remote Work Options